SELLAS Life Sciences Group, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/13/2024 | 2.29 M | $2.87 M | 28.36% | 3.36% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 1.46 M | $1.82 M | -11.20% | 2.13% |
| ANSON FUNDS MANAGEMENT LP | 11/15/2024 | 793,835 | $992,294 | 100.00% | 1.16% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 605,191 | $756,579 | 17.06% | 0.89% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 431,618 | $539,523 | 100.00% | 0.63% |
| OPUS CAPITAL GROUP, LLC | 10/31/2024 | 226,100 | $283,000 | 2.31% | 0.33% |
| STATE STREET CORP | 11/14/2024 | 174,529 | $218,161 | 30.22% | 0.26% |
| CITADEL ADVISORS LLC | 11/14/2024 | 162,800 | $203,500 | 9.85% | 0.24% |
| DIAMETRIC CAPITAL, LP | 11/13/2024 | 160,194 | $200,242 | 4.69% | 0.23% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 92,937 | $116,171 | 186.44% | 0.14% |
| VIRTU FINANCIAL LLC | 11/20/2024 | 79,241 | $99,000 | 24.12% | 0.12% |
| CITADEL ADVISORS LLC | 11/14/2024 | 74,700 | $93,375 | 538.46% | 0.11% |
| XTX TOPCO LTD | 11/14/2024 | 62,785 | $78,481 | 100.00% | 0.09% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 11/14/2024 | 58,338 | $72,923 | 4.69% | 0.09% |
| LPL FINANCIAL LLC | 11/08/2024 | 51,894 | $64,868 | 0.00% | 0.08% |
| MARINER, LLC | 11/13/2024 | 47,429 | $59,286 | 5.56% | 0.07% |
| CITADEL ADVISORS LLC | 11/14/2024 | 47,319 | $59,149 | 100.00% | 0.07% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 46,335 | $57,919 | -69.20% | 0.07% |
| JANE STREET GROUP, LLC | 11/15/2024 | 35,000 | $43,750 | 100.00% | 0.05% |
| MORGAN STANLEY | 11/14/2024 | 17,435 | $21,794 | 428.81% | 0.03% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 16,900 | $21,125 | 100.00% | 0.02% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 16,591 | $20,739 | 100.00% | 0.02% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 16,238 | $20,298 | 0.00% | 0.02% |
| COMMONWEALTH EQUITY SERVICES, LLC | 10/18/2024 | 15,554 | $19,000 | 0.00% | 0.02% |
| CALTON & ASSOCIATES, INC. | 10/21/2024 | 14,000 | $17,500 | 100.00% | 0.02% |
| EQUITABLE HOLDINGS, INC. | 11/14/2024 | 12,060 | $15,075 | -94.26% | 0.02% |
| NEMES RUSH GROUP LLC | 11/13/2024 | 10,000 | $10,100 | 0.00% | 0.01% |
| JPMORGAN CHASE & CO | 11/08/2024 | 5,789 | $7,236 | 100.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 3,709 | $4,636 | -72.79% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 1,660 | $2,075 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 526 | $658 | -8.84% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 11/12/2024 | 374 | $471 | 0.00% | 0.00% |
| FMR LLC | 11/13/2024 | 187 | $233 | 100.00% | 0.00% |
| PARKSIDE FINANCIAL BANK & TRUST | 11/07/2024 | 2 | $3 | 0.00% | 0.00% |
| ROYAL BANK OF CANADA | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| WEDBUSH SECURITIES INC | 11/08/2024 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 10/23/2024 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 11/15/2024 | 0 | $0 | -100.00% | 0.00% |
| BELVEDERE TRADING LLC | 11/01/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
SELLAS Life Sciences Group, Inc.institutional Ownership - FAQ's
During the previous two years, 38 institutional investors and hedge funds held shares of SELLAS Life Sciences Group, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 2.29 M
Anson Funds Management LP: 793,835
GEODE CAPITAL MANAGEMENT, LLC: 605,191
BlackRock Funding, Inc. /DE: 431,618
Opus Capital Group, LLC: 226,100
STATE STREET CORP: 174,529
7.89% of SELLAS Life Sciences Group, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 6.02 M shares in the last 24 months. This purchase volume represents approximately $5.60 M in transactions.